Diphtheria Market Size, Deep Analysis, Growth Statistics, Share, Trends And Forecast To 2033

The diphtheria market size has grown strongly in recent years. It will grow from $8.34 billion in 2023 to $8.91 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to vaccine development, immunization campaigns, increased awareness, healthcare infrastructure.

The diphtheria market size is expected to see strong growth in the next few years. It will grow to $11.51 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to emerging outbreaks, booster vaccination programs, global travel and migration, public health preparedness. Major trends in the forecast period include combination vaccines, telemedicine for vaccination, vaccine equity initiatives, public-private partnerships.

Market Overview -
Diphtheria is a bacterial illness caused by strains of bacteria called bacteria Corynebacterium diphtheriae which make a toxin that predominantly affects the mucous membranes of the throat and nose and can also affect other regions of the body in severe instances. It can be identified by throat discomfort, weakness, fever, swollen neck glands, breathing difficulties due to tissues clogging the nose and throat and difficulty in swallowing.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp

Rising Prevalence Of Bacterial Infections Fuels Growth In The Diphtheria Market
The rising prevalence of bacterial infections is expected to propel the growth of the diphtheria market going forward. A bacterial infection is a sickness or condition attributed to bacterial growth or the toxins produced by bacteria that invade the body. Diphtheria is a serious infection caused by bacteria strains that suppress the immune system and promote the proliferation of Corynebacterium diphtheria. For instance, in November 2022, according to a report published by the European Centre for Disease Prevention and Control, a Sweden-based public health organization, the number of reported infections of Acinetobacter species resistant to various antimicrobial groups was over doubled (+121%) the average in the year 2021 and more than 35,000 people die from antimicrobial-resistant infections in the EU each year. Furthermore, the number of Klebsiella pneumonia cases increased by 31% in 2020 and another 20% in the year 2021. Therefore, the rising prevalence of bacterial infections will drive the diphtheria market.

Competitive Landscape -
Major players in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.

Companies Innovate And Gain FDA Approval For Diphtheria Prevention Drugs
Companies operating in the diphtheria market are developing innovative drugs and getting approvals to sustain their position in the market. For instance, in October 2022, GlaxoSmithKline plc, a UK-based pharmaceutical and biotechnology company, announced that the US Food and Drug Administration (FDA) approved BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) for immunization throughout the third month of the pregnancy to help prevent pertussis (whooping cough) in infants younger than two months of age. The Tdap immunization administered during pregnancy gives the highest protection against whooping cough in the early months of life for newborns. Protective antibodies are transferred from mother to kid when pregnant women are immunized.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report

Key Segments -
The diphtheria market covered in this report is segmented -
1) By Type: Diphtheria; Skin Diphtheria; Other Types
2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
3) By Treatment: Antibiotics; Antitoxin; Other Treatments
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.